Just came across something pretty remarkable about Firefly Neuroscience. The company just announced they're making serious headway on building what could be the world's first real EEG/ERP-based foundation model of the human brain, and honestly, the numbers behind it are wild.

So here's what caught my attention - they expanded their commercial footprint by more than 20 times in 2025. That's not incremental growth, that's explosive. And their EEG/ERP brain scan volumes jumped 33-fold. After acquiring Evoke Neuroscience and pushing their own growth initiatives, they wrapped up the year with 99 commercial partners who collectively completed over 10,800 brain scans. The year-over-year metrics are insane too - partner sites grew 1,880% and clinical assessments hit 3,227% growth.

What's really interesting is their database now holds more than 191,000 EEG/ERP brain scans, apparently the largest standardized collection of its kind. They're using NVIDIA's L40S GPU acceleration to process this data, which makes sense given the computational demands of mapping the human brain at this scale. Their FDA-cleared brain analytics tech is designed to help with depression, dementia, anxiety, concussions, ADHD - basically a whole range of neurological conditions that need better diagnostic tools.

The CEO was pretty clear about the vision: they want to harness AI and EEG/ERP technology to actually transform how we understand and treat brain-related conditions. Building a foundation model of the human brain isn't small thinking, and the data they're accumulating suggests they're positioned to pull it off.

Stock-wise, AIFF has been trading between $0.62 and $6.00 over the past year, and it's currently at $1.23, up 80% recently. Clearly the market is paying attention to what they're doing. Whether this is the beginning of something bigger in neuroscience tech or just momentum, worth keeping an eye on.